Delivery Order SPE2DR25D3504-SPE2DR26F7CB1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 100 units, with a ceiling value of $2,743.30 and an ultimate completion date of November 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naltrexone 50 mg tablets (60-count) valued at $2,678.33 under a firm fixed-price contract. The award was made on January 5, 2026, with an ultimate completion date of January 6, 2026. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively small-value...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 60 units. This competitively awarded, non-set-aside contract has a ceiling value of $3,275.92 and is structured as a firm fixed-price delivery order with a completion date of November 5, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naltrexone 50mg tablets (30-count) under a firm fixed-price contract valued at $4,781. The award was made on December 4, 2025, with an ultimate completion date of January 2, 2026. This non-competitive delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 100 units, with a contract ceiling value of $1,277.11. This is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $6,715.74 to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets (30-count packaging). This contract is a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets (100-count units) under a firm fixed-price contract valued at $1,666.35. The award, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a competitively awarded, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 100 units, with a ceiling value of $3,908.57 and an ultimate completion date of December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naltrexone 50 mg tablets in quantities of 100 units, with a contract ceiling value of $1,041.59. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 26, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naltrexone 50 mg tablets (60-count packages) valued at $12,265.43, with a firm fixed price and an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded contract was issued on December 11, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7CB1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naltrexone 50 mg tablets (60-count supply) on January 5, 2026, with a ceiling value of $4,343.36 under a firm fixed-price contract type. The order, which is neither set-aside nor restricted, is expected to be completed by January 6, 2026, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Naltrexone is an opioid antagonist medication commonly used in federal healthcare programs, including military and veteran medical systems, for opioid use disorder treatment and pain management applications. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive global pharmaceutical support vehicle, which enables the company to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 1/4/26 |